销售和管理费用 更改
AbbVie USD 3.63B 54M 2026-06
Align Technology USD 462.67M 2.67M 2026-06
Bayer EUR 3.7B 356M 2026-03
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Charles River Laboratories USD 228.9M 69.47M 2026-06
Coherus Biosciences USD 15M 6.26M 2025-12
Dentsply International USD 364M 13M 2026-06
Eli Lilly USD 3.43B 496M 2026-06
Henry Schein USD 831M 22M 2026-06
Idexx Laboratories USD 288.09M 11.76M 2026-06
Illumina USD 273M 1000K 2026-06
IQVIA Holdings USD 574M 72M 2026-06
J&J USD 6.42B 381M 2026-06
Laboratory Of America USD 577.2M 26.2M 2026-06
Merck USD 2.89B 219M 2026-06
Neogen USD 99.8M 1.3M 2026-03
Pacira USD 91.81M 7.93M 2026-06
Perrigo USD 3.28B 3.02B 2026-06
Pfizer USD 3.41B 496M 2026-06
Phibro Animal Health USD 78.32M 10.24M 2025-12
Quest Diagnostics USD 529M 25M 2026-06
Sanofi EUR 2.63B 307M 2026-06
Sanofi EUR 2.49B 252M 2026-03
Zoetis USD 592M 4M 2026-06